The Japanese Market Presents Additional Opportunities for Drug Development and Commercialization
Market experts recently met to discuss the opportunities – as well as the challenges – for pharma in Japan.
This illuminating roundtable report from Pharma Intelligence, presented in partnership with CMIC, explores:
- The critical keys to creating a successful plan
- An important factor in fostering successful Japanese business relationships
- Essential regulatory considerations for commercialization
- Insights into cultural elements of communication
1 August 2022